BioSpace News Archive

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will present clinical data on AXS-05 in the treatment of major depressive disorder (MDD) at the 33 rd Congress of the European College of Neuropsychopharmacology (ECNP), to be held virtually, September 12-15. AXS-05 (dextromethorphan/bupropion modulated delivery tablet

Centene Corporation (NYSE: CNC) announced today it will participate at the Morgan Stanley Virtual 18 th Annual Global Healthcare Conference, to be held September 14-September 18, 2020 . Centene will participate in a virtual format on Monday, September 14, 2020 , at 10:30 a.m. Eastern Daylight Time (EDT). A simultaneous l

Hemp-derived, non-psychoactive cannabinoid manufacturer Folium Biosciences welcomes Kandy Anand, former Chief Growth Officer at Molson Coors Brewing Company, to its Board of Directors.